These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6147393)

  • 1. Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.
    Girotti F; Carella F; Scigliano G; Grassi MP; Soliveri P; Giovannini P; Parati E; Caraceni T
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):848-52. PubMed ID: 6147393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea.
    Deroover J; Baro F; Bourguignon RP; Smets P
    Curr Med Res Opin; 1984; 9(5):329-38. PubMed ID: 6241563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiapride in the treatment of Huntington's chorea.
    Roos RA; Buruma OJ; Bruyn GW; Kemp B; van der Velde EA
    Acta Neurol Scand; 1982 Jan; 65(1):45-50. PubMed ID: 6461156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.
    van Vugt JP; Siesling S; Vergeer M; van der Velde EA; Roos RA
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):35-9. PubMed ID: 9221965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
    Piolti R; Appollonio I; Perego M; Pozzi C; Rovati L; Ferrarese C; Frattola L
    Eur Neurol; 1995; 35(6):344-8. PubMed ID: 8591802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptically induced dystonia in Huntington's disease: a case report.
    Schott K; Ried S; Stevens I; Dichgans J
    Eur Neurol; 1989; 29(1):39-40. PubMed ID: 2523309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiapride in 12 Huntington's disease patients.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):292. PubMed ID: 3156967
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypokinesia in Huntington's disease.
    van Vugt JP; van Hilten BJ; Roos RA
    Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dexamethasone therapy in Huntington chorea: preliminary results].
    Nuti A; Maremmani C; Ceravolo R; Pavese N; Bonuccelli U; Muratorio A
    Riv Neurol; 1991; 61(6):225-7. PubMed ID: 1839936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment of Huntington's chorea with lisuride.
    Frattola L; Albizzati MG; Alemani A; Bassi S; Ferrarese C; Trabucchi M
    J Neurol Sci; 1983 May; 59(2):247-53. PubMed ID: 6222164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamine oxidase activity in Huntington's chorea.
    Mann J; Chiu E
    J Neurol Neurosurg Psychiatry; 1978 Sep; 41(9):809-12. PubMed ID: 151126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
    Saft C; Lauter T; Kraus PH; Przuntek H; Andrich JE
    BMC Neurol; 2006 Feb; 6():11. PubMed ID: 16507108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.
    Roos RA; de Haas EJ; Buruma OJ; de Wolff FA
    Eur J Clin Pharmacol; 1986; 31(2):191-4. PubMed ID: 2948825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose olanzapine in Huntington's disease.
    Bonelli RM; Niederwieser G; Tribl GG; Költringer P
    Int Clin Psychopharmacol; 2002 Mar; 17(2):91-3. PubMed ID: 11890191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Haloperidol, reserpine, l-dopa and amantidine in the treatment of Huntington chorea (author's transl)].
    Candelise L
    Riv Patol Nerv Ment; 1976; 96(1):54-62. PubMed ID: 134449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-dimethylaminoethanol (Deanol) in Huntington's chorea.
    Caraceni TA; Girotti F; Celano I; Parati E; Balboni L
    J Neurol Neurosurg Psychiatry; 1978 Dec; 41(12):1114-8. PubMed ID: 153384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychiatric problems in a motor disorder: psychosis in Huntington's disease].
    van der Weijde E; Schadé A
    Tijdschr Psychiatr; 2015; 57(3):215-9. PubMed ID: 25856745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.